Deep knowledge on
small-molecule drugs and
the 90,000 global patents
covering them

Request a free trial

No credit card. No commitment.

Plans and Pricing

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: lidocaine hydrochloride

« Back to Dashboard
Lidocaine hydrochloride is the generic ingredient in thirty-five branded drugs marketed by Akorn, Carlisle, Abbott, Abraxis Pharm, Agila Speclts, Bel Mar, Dell Labs, Elkins Sinn, Eurohlth Intl Sarl, Gd Searle Llc, Graham Chem, Hospira, Intl Medication, Luitpold, Lyphomed, Miles, Mylan Pharms Inc, Watson Labs, Wyeth Ayerst, Baxter Hlthcare, B Braun, Fresenius Kabi Usa, Aurobindo Pharma Ltd, Pharmaton, Meridian Medcl Techn, Astrazeneca, Dentsply Pharm, Banner Life Sciences, Sagent Pharms, G And W Labs Inc, Watson Labs Inc, Oak Pharms, Hi Tech Pharma, Wockhardt, Actavis Mid Atlantic, Vintage, Roxane, Kendall Il, Igi Labs Inc, Paco, Powder Pharms, and Pfizer, and is included in ninety-seven NDAs. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

This ingredient has seventy-two patent family members in thirty-four countries.

There are twenty-nine drug master file entries for lidocaine hydrochloride. Fourteen suppliers are listed for this compound.

Summary for Generic Name: lidocaine hydrochloride

Drug Master File Entries: see list29
Suppliers / Packaging: see list90
Therapeutic Class:Anesthetics
Formulation / Manufacturing:see details

Clinical Trials for: lidocaine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dell Labs
lidocaine hydrochloride
INJECTABLE;INJECTION083387-001Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
Watson Labs
lidocaine hydrochloride
INJECTABLE;INJECTION080377-001Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
lidocaine hydrochloride
INJECTABLE;INJECTION088331-001May 17, 1984DISCNNo<disabled><disabled>
B Braun
lidocaine hydrochloride
INJECTABLE;INJECTION018967-002Mar 30, 1984DISCNNo<disabled><disabled>
Fresenius Kabi Usa
lidocaine hydrochloride
INJECTABLE;INJECTION010417-001Approved Prior to Jan 1, 1982RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: lidocaine hydrochloride

Country Document Number Publication Date
China1120852Apr 17, 1996
Germany69729634Jun 30, 2005
European Patent Office0951917Jan 05, 2000
World Intellectual Property Organization (WIPO)2008135719Nov 13, 2008
United Kingdom9321356Dec 08, 1993
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn